3/24
02:27 pm
sepn
Septerna (SEPN) had its price target raised by JPMorgan Chase & Co. from $34.00 to $38.00. They now have an "overweight" rating on the stock.
Low
Report
Septerna (SEPN) had its price target raised by JPMorgan Chase & Co. from $34.00 to $38.00. They now have an "overweight" rating on the stock.
3/14
01:32 am
sepn
Low
Report
3/11
10:19 am
sepn
Septerna (SEPN) had its price target raised by Truist Financial Corporation from $34.00 to $35.00. They now have a "buy" rating on the stock.
Medium
Report
Septerna (SEPN) had its price target raised by Truist Financial Corporation from $34.00 to $35.00. They now have a "buy" rating on the stock.
3/10
12:07 pm
sepn
Septerna (SEPN) had its "overweight" rating reaffirmed by Cantor Fitzgerald.
Low
Report
Septerna (SEPN) had its "overweight" rating reaffirmed by Cantor Fitzgerald.
3/9
05:04 pm
sepn
Septerna, Inc. GAAP EPS of -$0.24 beats by $0.02, revenue of $24.1M beats by $8.54M [Seeking Alpha]
Medium
Report
Septerna, Inc. GAAP EPS of -$0.24 beats by $0.02, revenue of $24.1M beats by $8.54M [Seeking Alpha]
3/9
04:42 pm
sepn
Septerna Highlights Pipeline Progress and Reports Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
Medium
Report
Septerna Highlights Pipeline Progress and Reports Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
3/9
04:05 pm
sepn
Septerna Highlights Pipeline Progress and Reports Fourth Quarter and Full Year 2025 Financial Results
Medium
Report
Septerna Highlights Pipeline Progress and Reports Fourth Quarter and Full Year 2025 Financial Results
3/3
10:18 am
sepn
Septerna (SEPN) had its price target raised by Wells Fargo & Company from $28.00 to $48.00. They now have an "overweight" rating on the stock.
Low
Report
Septerna (SEPN) had its price target raised by Wells Fargo & Company from $28.00 to $48.00. They now have an "overweight" rating on the stock.
3/2
01:00 pm
sepn
Septerna (SEPN) had its price target raised by HC Wainwright from $35.00 to $40.00. They now have a "buy" rating on the stock.
Low
Report
Septerna (SEPN) had its price target raised by HC Wainwright from $35.00 to $40.00. They now have a "buy" rating on the stock.
3/1
10:14 am
sepn
Septerna Announces Positive Phase 1 Data for SEP-631, an Oral MRGPRX2 NAM for the Treatment of Mast Cell-Driven Diseases, and Outlines Initial Phase 2 Development Strategy [Yahoo! Finance]
Low
Report
Septerna Announces Positive Phase 1 Data for SEP-631, an Oral MRGPRX2 NAM for the Treatment of Mast Cell-Driven Diseases, and Outlines Initial Phase 2 Development Strategy [Yahoo! Finance]
3/1
09:45 am
sepn
Septerna Announces Positive Phase 1 Data for SEP-631, an Oral MRGPRX2 NAM for the Treatment of Mast Cell-Driven Diseases, and Outlines Initial Phase 2 Development Strategy
Low
Report
Septerna Announces Positive Phase 1 Data for SEP-631, an Oral MRGPRX2 NAM for the Treatment of Mast Cell-Driven Diseases, and Outlines Initial Phase 2 Development Strategy
2/26
06:28 am
sepn
Septerna (SEPN) was upgraded by Zacks Research from "strong sell" to "hold".
Low
Report
Septerna (SEPN) was upgraded by Zacks Research from "strong sell" to "hold".
2/24
08:00 am
sepn
Septerna to Present at TD Cowen 46th Annual Health Care Conference
Medium
Report
Septerna to Present at TD Cowen 46th Annual Health Care Conference
2/10
04:05 pm
sepn
Septerna Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Septerna Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
2/10
08:00 am
sepn
Septerna to Present Data from Phase 1 Clinical Trial of SEP-631 for the Treatment of Mast Cell-Driven Diseases at 2026 AAAAI Annual Meeting
Low
Report
Septerna to Present Data from Phase 1 Clinical Trial of SEP-631 for the Treatment of Mast Cell-Driven Diseases at 2026 AAAAI Annual Meeting
1/27
05:58 am
sepn
Septerna (NASDAQ:SEPN) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
Low
Report
Septerna (NASDAQ:SEPN) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
1/20
07:17 am
sepn
Septerna (NASDAQ:SEPN) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Medium
Report
Septerna (NASDAQ:SEPN) had its "buy" rating reaffirmed by analysts at HC Wainwright.
1/10
01:07 am
sepn
Low
Report
1/8
04:17 pm
sepn
Septerna Expands Leadership with Appointment of Industry Veteran Mark A. Wilson as Chief Legal Officer [Yahoo! Finance]
Low
Report
Septerna Expands Leadership with Appointment of Industry Veteran Mark A. Wilson as Chief Legal Officer [Yahoo! Finance]
1/8
04:05 pm
sepn
Septerna Expands Leadership with Appointment of Industry Veteran Mark A. Wilson as Chief Legal Officer
Low
Report
Septerna Expands Leadership with Appointment of Industry Veteran Mark A. Wilson as Chief Legal Officer